Research and Reviews: A Journal of Pharmacology Original Research

Prevalence and Distribution of Staphylococcus Aureus in Clinical Samples Across Age Groups

  1. Akshita Gupta Department of Basics and Applied Sciences, Nirwan University Jaipur
  2. Rekha Karwasra Department of Basics and Applied Sciences, Nirwan University Jaipur

Abstract

The bacteria that cause everything from ordinary skin infections to serious illnesses is called Staphylococcus aureus. It is now known that Staphylococcus aureus may develop resistance to a variety of drugs. Staphylococcus aureus has been displaying an unusual kind of resistance to antibiotics, especially to those based on β-lactum. As a result, Methicillin Resistant Staphylococcus Aureus (MRSA) is the new name for the resistant strain of Staphylococcus aureus. The prevalence and distribution of Staphylococcus aureus (S. aureus) in different clinical samples and age groups are examined in this research. We examined samples from patients ranging in age from 0 to over 80 years, including blood, high vaginal swabs (HVS), nasal swabs, pus, skin, ear swabs, wounds, and urine, using a crosssectional design. Staphylococcus aureus is a significant pathogen responsible for a variety of infections, ranging from minor skin conditions to life-threatening diseases. This study aims to investigate the prevalence and distribution of Staphylococcus aureus in clinical samples collected from different age groups. The study also highlighted the presence of methicillin-resistant Staphylococcus aureus (MRSA) in 12% of the positive samples, with a notable increase in prevalence among the elderly population. These findings underscore the need for targeted infection control strategies and the importance of agespecific interventions to manage and reduce the spread of Staphylococcus aureus in healthcare settings.

Keywords

References (18)

  1. Anderson, D. J., Podgorny, K., Berríos-Torres, S. I., Bratzler, D. W., Dellinger, E. P., Greene, L., . & Kaye, K. S. (2014). Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infection Control & Hospital Epidemiology, 35(S2), S66-S88.
  2. Bengtsson-Palme, J., Kristiansson, E., & Larsson, D. J. (2018). Environmental factors influencing the development and spread of antibiotic resistance. FEMS microbiology reviews, 42(1), fux053.
  3. Berríos-Torres, S. I. (2016). Evidence-based update to the US Centers for Disease Control and Prevention and Healthcare Infection Control Practices Advisory Committee guideline for the prevention of surgical site infection: developmental process. Surgical infections, 17(2), 256-261.
  4. Boswihi, S. S., & Udo, E. E. (2018). Methicillin-resistant Staphylococcus aureus: An update on the epidemiology, treatment options and infection control. Current Medicine Research and Practice, 8(1), 18-24.
  5. Dezfulian, C., Lavelle, J., Nallamothu, B. K., Kaufman, S. R., & Saint, S. (2003). Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis. Critical care medicine, 31(9), 2385-2390.
  6. Dimassi, A., & Rushton, T. (2009). Right-sided infective endocarditis due to methicillin-resistant Staphylococcus aureus in an injecting drug user: outbreak or slow epidemic?. West Virginia Medical Journal, 105(1), 18-20.
  7. Gandra, S., Tseng, K. K., Arora, A., Bhowmik, B., Robinson, M. L., Panigrahi, B., .. & Klein, E. Y. (2019). The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study. Clinical Infectious Diseases, 69(4), 563-570.
  8. Garoy, E. Y., Gebreab, Y. B., Achila, O. O., Tekeste, D. G., Kesete, R., Ghirmay, R., ... & Tesfu, T. (2019). Methicillin-resistant Staphylococcus aureus (MRSA): prevalence and antimicrobial sensitivity pattern among patients—a multicenter study in Asmara, Eritrea. Canadian Journal of Infectious Diseases and Medical Microbiology, 2019.
  9. Goolam Mahomed, T., Kock, M. M., Masekela, R., Hoosien, E., & Ehlers, M. M. (2018). Genetic relatedness of Staphylococcus aureus isolates obtained from cystic fibrosis patients at a tertiary academic hospital in Pretoria, South Africa. Scientific Reports, 8(1), 12222.
  10. Hashemizadeh, Z., Hadi, N., Mohebi, S., Kalantar-Neyestanaki, D., & Bazargani, A. (2019). Characterization of SCCmec, spa types and Multi Drug Resistant of methicillin-resistant Staphylococcus aureus isolates among inpatients and outpatients in a referral hospital in Shiraz, Iran. BMC research notes, 12, 1-6.
  11. Kavanagh, K. T., Abusalem, S., & Calderon, L. E. (2018). View point: gaps in the current guidelines for the prevention of Methicillin-resistant Staphylococcus aureus surgical site infections. Antimicrobial Resistance & Infection Control, 7(1), 112.
  12. Naber, C. K. (2009). Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clinical infectious diseases, 48(Supplement_4), S231-S237.
  13. Nithya, V., Rathinam, S., Karthikeyan, R. S. G., & Lalitha, P. (2019). A ten year study of prevalence, antimicrobial susceptibility pattern, and genotypic characterization of Methicillin resistant Staphylococcus aureus causing ocular infections in a tertiary eye care hospital in South India. Infection, Genetics and Evolution, 69, 203-210.
  14. Parvizi, J., Azzam, K., Ghanem, E., Austin, M. S., & Rothman, R. H. (2009). Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clinical Orthopaedics and Related Research®, 467(7), 1732-1739.
  15. Sakr, A., Brégeon, F., Mège, J. L., Rolain, J. M., & Blin, O. (2018). Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Frontiers in microbiology, 9, 415974.
  16. Shahsavan S, Emaneini M, Noorazar Khoshgnab B, Khoramian B, Asadollahi P, Aligholi M, et al. A high prevalence of mupirocin and macrolide resistance determinant among Staphylococcus aureus strains isolated from burnt patients. Burns. 2012;38(3):378-382. doi:10.1016/j.burns.2011.09.004
  17. Niemann S, Ehrhardt C, Medina E, Warnking K, Tuchscherr L, Heitmann V, et al. Combined Action of Influenza Virus and Staphylococcus aureus Panton–Valentine Leukocidin Provokes Severe Lung Epithelium Damage. The Journal of Infectious Diseases. 2012;206(7):1138-1148. doi:10.1093/infdis/jis468
  18. Tinelli M, Monaco M, Vimercati M, Ceraminiello A, Pantosti A. Methicillin-SusceptibleStaphylococcus aureusin Skin and Soft Tissue Infections, Northern Italy. Emerging Infectious Diseases. 2009;15(2):250-257. doi:10.3201/eid1502.080010
Support